Skip to main content
INTCO MEDICAL TECHNOLOGY CO., LTD. logo

INTCO MEDICAL TECHNOLOGY CO., LTD. — Investor Relations & Filings

Ticker · 300677 ISIN · CNE100003456 LEI · 549300U6H4L6SSU31U28 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,902 across all filing types
Latest filing 2025-10-15 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300677

About INTCO MEDICAL TECHNOLOGY CO., LTD.

https://www.intcomedical.com.cn

INTCO Medical Technology Co., Ltd. is a high-tech manufacturer specializing in the research, development, production, and marketing of medical consumables and durable medical equipment. The company's primary product portfolio includes a wide range of disposable medical gloves, such as nitrile, vinyl, and latex varieties, which serve as critical protective gear in healthcare and industrial settings. Beyond consumables, the firm produces durable medical equipment including manual and electric wheelchairs, hospital beds, and patient mobility aids. It also offers physical therapy products like cold and hot packs and various medical electrodes. With a focus on large-scale production and advanced manufacturing technology, the company serves a global clientele across healthcare, laboratory, and food service sectors. Its operations emphasize quality control and compliance with international standards to ensure product safety and reliability.

Recent filings

Filing Released Lang Actions
英科医疗关于向激励对象授予2025年限制性股票激励计划预留股份的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the grant of reserved shares under a 2025 restricted stock incentive plan by Yingke Medical Technology Co., Ltd. It includes specifics about the number of shares, grant price, vesting periods, performance conditions, and approvals by the board and shareholders. The content focuses on the company's stock incentive plan, including the allocation to management and key employees, performance targets, and legal and financial advisor opinions. It is not a financial report, earnings release, or regulatory filing but a formal announcement of a capital/financing activity related to share-based compensation. Therefore, the document fits best under the category of Capital/Financing Update (CAP). The document length and detail confirm it is not a brief announcement or a report publication notice, but a substantive disclosure about a financing-related equity incentive plan.
2025-10-15 Chinese
英科医疗董事会薪酬与考核委员会关于2025年限制性股票激励计划预留授予激励对象名单（预留授予日）的核查意见
Remuneration Information Classification · 95% confidence The document is a formal announcement from the Board's Remuneration and Assessment Committee regarding the verification opinion on the reserved grant list of incentive targets under the 2025 restricted stock incentive plan. It discusses compliance with laws and regulations, eligibility of incentive recipients, and approval of the reserved grant date and price. The content focuses on remuneration and stock incentive plan details, specifically related to executive compensation and stock awards. It is not a full report, financial statement, or earnings release, but a remuneration-related announcement. Therefore, it fits best under the Remuneration Information category (DEF 14A). The document length is short and it is an official committee opinion on remuneration matters, not a general regulatory filing or report publication announcement.
2025-10-15 Chinese
上海荣正企业咨询服务（集团）股份有限公司关于英科医疗科技股份有限公司2025年限制性股票激励计划调整及预留授予相关事项之独立财务顾问报告
Regulatory Filings
2025-10-15 Chinese
英科医疗2025年限制性股票激励计划预留授予激励对象名单（预留授予日）
Capital/Financing Update Classification · 95% confidence The document is a list of reserved grant recipients for a restricted stock incentive plan for the year 2025, including names, positions, and stock quantities. It is issued by the company's board of directors and dated October 15, 2025. The content focuses on stock incentive allocations to senior management and does not contain financial statements, earnings data, or regulatory certifications. It is an announcement related to share-based compensation, specifically the allocation of restricted stock to executives. This fits best under the category of Capital/Financing Update (CAP), as it relates to company financing activities through stock incentives.
2025-10-15 Chinese
高朋（上海）律师事务所关于英科医疗科技股份有限公司2025年限制性股票激励计划授予价格调整及预留部分授予相关事项的法律意见书
Regulatory Filings
2025-10-15 Chinese
英科医疗关于调整2025年限制性股票激励计划相关事项的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding adjustments to the 2025 restricted stock incentive plan of Yingke Medical Technology Co., Ltd. It details the decision-making process, the adjustment of the grant price of restricted stock, and related approvals by the board and committees. The document is relatively short (2968 characters) and focuses on a specific corporate action related to stock incentives, including legal opinions and board resolutions. It does not contain comprehensive financial statements or detailed financial performance data. It is not a full annual or interim report, nor is it a call transcript or earnings release. It is not a proxy solicitation or voting result announcement. The content fits best with a Capital/Financing Update (CAP) as it relates to stock incentive plan adjustments and related corporate financing matters.
2025-10-15 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.